Stifel raises Glaukos stock price target to $190 on revenue outlook
Stifel raised its price target on Glaukos Corporation (NYSE:GKOS) to $190 from $175, maintaining a Buy rating, based on positive surveys for iDose and Epioxa and a strong revenue outlook, projecting $1.0 billion or more in 2027. This follows Glaukos exceeding Q2 2026 earnings …